Candela Laser Receives FDA Clearance
WAYLAND, Mass., April 23 -- Candela Corp.'s new GentleYAG Nd:YAG long-pulse laser has received clearance from the US Food and Drug Administration for hair reduction and the treatment of vascular lesions. The GentleYAG facilitates hair removal in darker skinned patients, including skin types V and VI.
"FDA clearance for the GentleYAG laser is very significant for the laser hair removal market," said Gerard E. Puorro, Candela's president and CEO. "This is our first laser that completely meets the hair removal needs of darker skinned persons, while being entirely suitable for all skin types. The laser is smaller, lighter, more affordable and easier to use than what was previously available. It will improve the in-office hair removal capabilities of physicians and other practitioners."
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024